tiprankstipranks
Trending News
More News >
Blue Chip India Ltd (IN:BLUECHIP)
:BLUECHIP
India Market

Blue Chip India Ltd (BLUECHIP) AI Stock Analysis

Compare
2 Followers

Top Page

IN:BLUECHIP

Blue Chip India Ltd

(BLUECHIP)

Select Model
Select Model
Select Model
Underperform 40 (OpenAI - 5.2)
Rating:40Underperform
Price Target:
₹3.50
▼(-11.84% Downside)
The score is held down primarily by very weak financial performance (sharp revenue decline, large losses, negative operating/free cash flow, and negative equity). Technicals add further pressure with the price below key moving averages and a negative MACD. Valuation provides limited support because the negative P/E reflects ongoing losses and there is no dividend yield data.
Positive Factors
Low reported debt
Zero reported debt removes interest burdens and preserves financial flexibility. Over the next 2–6 months this reduces mandatory cash outflows, giving management scope to prioritize working capital, restructure operations, or seek equity funding without immediate refinancing pressure.
Historical cash-generation capacity
Prior years of strong operating cash flow show the business can generate cash under better conditions. Structurally, this indicates the model can be cash-accretive if revenue and cost controls recover, supporting medium-term recovery scenarios without permanent model redesign.
High gross profit margins
Sustained gross margins near 56–58% imply the core product/service has meaningful contribution per unit sold. If overheads and operating expenses are reduced or revenue stabilizes, these margins provide a realistic path to restoring operating profitability over several quarters.
Negative Factors
Negative shareholders' equity
Negative equity is a structural balance-sheet weakness reflecting cumulative losses that exceed capital. It constrains access to credit, weakens creditor confidence, and typically requires capital injection or sustained profits to remediate, posing solvency and strategic constraints.
Sharp revenue decline
A near 40% revenue drop undermines scale economics and fixed-cost absorption. Persistent top-line deterioration signals demand or execution issues that must be arrested to restore margins and cash flow; recovery requires structural fixes, not short-term cyclical changes.
Recurring cash burn
Consecutive negative operating and free cash flows deplete liquidity and raise funding risk. Absent a clear return to positive cash generation, the company will rely on external financing or equity, limiting investment capacity and threatening operational continuity over the medium term.

Blue Chip India Ltd (BLUECHIP) vs. iShares MSCI India ETF (INDA)

Blue Chip India Ltd Business Overview & Revenue Model

Company DescriptionBlue Chip India Limited engages in the fund-based activities in India. It sells equity shares; and provides loans. The company was incorporated in 1993 and is based in Kolkata, India.
How the Company Makes Money

Blue Chip India Ltd Financial Statement Overview

Summary
Financial health is fragile: FY2025 revenue fell sharply (~-38.7% YoY), profitability is deeply negative with a large net loss, operating/free cash flow were negative, and equity turned negative in FY2025 (a major balance-sheet red flag). Low reported debt is a mitigating factor but does not offset the current loss and cash-burn trend.
Income Statement
12
Very Negative
Operating performance is very weak and deteriorating. Revenue fell sharply in FY2025 (down ~38.7% YoY), and profitability is deeply negative, with FY2025 showing a large net loss (net margin around -42x revenue) and negative operating earnings. While gross profit margin appears positive in FY2024–FY2025 (~56–58%), that has not translated into sustainable bottom-line profits, and results have been volatile over the period.
Balance Sheet
18
Very Negative
Leverage is low (FY2025 total debt is zero), which reduces financial risk; however, the balance sheet quality is pressured by negative equity in FY2025 (stockholders’ equity turned to about -6.9M), a major red flag that limits financial flexibility. Prior years showed positive equity and low debt-to-equity, but the swing to negative equity alongside ongoing losses signals rising balance-sheet stress.
Cash Flow
20
Very Negative
Cash generation is inconsistent and currently weak. FY2025 operating cash flow and free cash flow were negative (about -1.36M), following another negative year in FY2024 (about -0.10M). Although there were years with strong positive cash flow (e.g., FY2021 and FY2022), the recent shift back to cash burn and negative cash coverage indicates reduced cash sustainability and higher funding risk if losses persist.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue923.00K619.00K1.04M359.00K107.00K9.00K
Gross Profit3.00K347.00K597.00K-64.00K-506.00K-1.19M
EBITDA-1.78M-26.05M-1.21M-2.12M-2.49M-2.93M
Net Income-26.66M-26.05M-29.37M6.89M-2.49M-2.98M
Balance Sheet
Total Assets0.0051.27M67.01M94.80M100.28M72.72M
Cash, Cash Equivalents and Short-Term Investments353.00K290.00K7.81M61.57M184.00K219.00K
Total Debt0.000.00992.00K0.00957.00K0.00
Total Liabilities6.93M58.20M46.73M46.89M61.55M58.85M
Stockholders Equity-6.93M-6.93M20.28M47.91M38.73M13.86M
Cash Flow
Free Cash Flow0.00-1.36M-98.00K-5.55M27.55M18.37M
Operating Cash Flow0.00-1.36M-98.00K-5.55M27.55M18.37M
Investing Cash Flow0.001.17M473.00K-2.50M-27.57M-18.74M
Financing Cash Flow0.000.000.007.99M-15.00K538.13K

Blue Chip India Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
63
Neutral
₹341.50M1.90-39.65%-9.12%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
54
Neutral
₹456.03M-2.901.36%-143.39%-166.54%
53
Neutral
₹433.65M-2.075.12%
49
Neutral
₹285.25M-15.36-12.64%-390.34%
48
Neutral
₹210.95M-5.11-62.38%21.41%
40
Underperform
₹192.46M-6.73
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:BLUECHIP
Blue Chip India Ltd
3.42
-4.79
-58.34%
IN:21STCENMGM
Twentyfirst Century Management Services Limited
39.68
-38.82
-49.45%
IN:HBSL
HB Stockholdings Ltd.
64.00
-36.58
-36.37%
IN:KHANDSE
Khandwala Securities Limited
18.70
-9.80
-34.39%
IN:NAGREEKCAP
Nagreeka Capital & Infrastructure Limited
25.01
-10.98
-30.51%
IN:ONELIFECAP
Onelife Capital Advisors Limited
15.37
-0.55
-3.45%

Blue Chip India Ltd Corporate Events

Blue Chip India Board Sets February EGM Date and Approves E-Voting Framework
Jan 12, 2026

Blue Chip India Ltd has announced that its board met on 12 January 2026 and approved the convening of the company’s first Extraordinary General Meeting (EGM) for the 2025-26 financial year, which has been rescheduled to 6 February 2026 and will be conducted via video conference and other audio-visual means. The board set 30 January 2026 as the cut-off date to determine shareholders eligible for remote e-voting and participation in the EGM, appointed a practicing company secretary as scrutinizer for the e-voting process, engaged CDSL to provide remote and on-meeting e-voting facilities, and confirmed that the registers of beneficial owners, members and share transfer books will remain open during this period, underscoring the company’s focus on compliant, fully electronic shareholder governance processes.

Blue Chip India Closes Trading Window Ahead of Quarterly Results
Dec 27, 2025

Blue Chip India Ltd has announced that, in line with the Securities and Exchange Board of India’s Prohibition of Insider Trading Regulations and its own code of conduct, it is temporarily closing the trading window for its securities to designated persons and their immediate relatives. The trading window will remain shut from 1 January 2026 until 48 hours after the company announces its unaudited financial results for the quarter ended 31 December 2025, a compliance step aimed at preventing insider trading and ensuring fair disclosure for all market participants.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 04, 2026